Spoken by: RoX

Would you like to get more insights, hear our opinion or stay up-to-date on the things that matter to us? Then follow our blog!

REESI – building an AI engine that will accelerate clinical research
With the project REESI Christian is building a digital platform that matches clinical trials with the medical data of the patient. Therewith, he aims to accelerate clinical research timelines. https://youtu.be/wIcrlVH2UF8    
Read more
A look into the DiGA world: Medical devices in risk class IIb will be able to get reimbursement as DiGA in the future
Digital health applications (DiGA) have so far been limited to low-risk class I and IIa medical devices. This means that products for the self-management of certain diseases are currently excluded from reimbursement. As part of the current digitization strategy, the...
Read more
Insights into the life of an Entrepreneur in Residence
Christoph is one of our “Entrepreneurs in Residence” at RoX. Until last year he was working as a gynecologist in a clinic. Would you like to know what brought him to the venture builder RoX? And what are his actual tasks and what does he love most about it? Then...
Read more
Welcome to our blog!
In this format, we would like to provide you with insights into our work at RoX, share our opinion around the topics of digital health and let you know about things that matter to us. You may be asking yourself: what do you firmly believe in? Well, I’m pretty clear...
Read more
A look into the DiGA world: Medical devices in risk class IIb will be able to get reimbursement as DiGA in the future

A look into the DiGA world: Medical devices in risk class IIb will be able to get reimbursement as DiGA in the future

by | May 19, 2023

Digital health applications (DiGA) have so far been limited to low-risk class I and IIa medical devices. This means that products for the self-management of certain diseases are currently excluded from reimbursement. As part of the current digitization strategy, the German Federal Ministry of Health recently announced that reimbursement via DiGA listing will be extended to medical devices in risk class IIb in the future.

read more